Toxins · 2023 · 11 citations · 35 references
MedicinePlastic SurgerySurgeryAesthetic SurgeryLocal AnesthesiaReconstructive SurgeryBotulinum Toxin TherapyBotulinum Toxin TreatmentBreast SurgeryScar FormationScar ManagementBotulinum Toxin DosageNeurotoxin InjectionsPrimary Outcome AnalysisScar HealingScar Outcome MeasurementStandard Method Of MeasurementSubcutaneous MastectomySubcutaneous Scar Management
BACKGROUND: Subcutaneous mastectomies in transmen have been gaining popularity. However, post-operative scars are an inevitable consequence. Recently, Botulinum neurotoxin A (BoNT-A) has shown positive effects in scar prevention. The objective of this study is to investigate the effectiveness of BoNT-A in scar prevention. METHODS: Fifteen patients who had undergone subcutaneous mastectomy were included. At 14 days post-surgery, either incoBoNT-A or a placebo was injected into the scar on each side. The primary outcome assessment measured the scar's severity using the Vancouver Scar Scale (VSS) and the Patient and Observer Scar Assessment Scale (POSAS). The secondary outcome assessment evaluated the scar's color using a standard measurement device. Outcome assessments were conducted until 6 months post-surgery. RESULTS: < 0.001). The objective assessment revealed a statistically significant decrease in redness values in the BoNT-A group compared to the placebo at 3 and 6 months. CONCLUSION: BoNT-A has demonstrated effectiveness in scar prevention by reducing the severity of postoperative scar formation and improving overall scar appearance.
35
Quality of life of patients with keloid and hypertrophic scarring
Oliver Bock, Gerhard Schmid‐Ott, Peter Malewski et al. · Archives of Dermatological Research · 2006 · 505 citations
Medicine, Dermatology, Surgery +9
Temporal Trends in Gender-Affirming Surgery Among Transgender Patients in the United States
Joseph K. Canner, Omar Harfouch, Lisa M. Kodadek et al. · JAMA Surgery · 2018 · 364 citations · Full text